JP2013544872A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544872A5
JP2013544872A5 JP2013542577A JP2013542577A JP2013544872A5 JP 2013544872 A5 JP2013544872 A5 JP 2013544872A5 JP 2013542577 A JP2013542577 A JP 2013542577A JP 2013542577 A JP2013542577 A JP 2013542577A JP 2013544872 A5 JP2013544872 A5 JP 2013544872A5
Authority
JP
Japan
Prior art keywords
heterocycle
alkyl
alkynyl
alkenyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013542577A
Other languages
English (en)
Japanese (ja)
Other versions
JP6050241B2 (ja
JP2013544872A (ja
Filing date
Publication date
Priority claimed from GBGB1021103.5A external-priority patent/GB201021103D0/en
Application filed filed Critical
Publication of JP2013544872A publication Critical patent/JP2013544872A/ja
Publication of JP2013544872A5 publication Critical patent/JP2013544872A5/ja
Application granted granted Critical
Publication of JP6050241B2 publication Critical patent/JP6050241B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013542577A 2010-12-13 2011-12-13 神経変性疾患の治療のための新規化合物 Expired - Fee Related JP6050241B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1021103.5A GB201021103D0 (en) 2010-12-13 2010-12-13 New compounds for the treatment of neurodegenerative diseases
GB1021103.5 2010-12-13
PCT/EP2011/072568 WO2012080221A1 (en) 2010-12-13 2011-12-13 New compounds for the treatment of neurodegenerative diseases

Publications (3)

Publication Number Publication Date
JP2013544872A JP2013544872A (ja) 2013-12-19
JP2013544872A5 true JP2013544872A5 (https=) 2015-01-29
JP6050241B2 JP6050241B2 (ja) 2016-12-21

Family

ID=43567100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013542577A Expired - Fee Related JP6050241B2 (ja) 2010-12-13 2011-12-13 神経変性疾患の治療のための新規化合物

Country Status (12)

Country Link
US (1) US9266832B2 (https=)
EP (1) EP2651888B1 (https=)
JP (1) JP6050241B2 (https=)
CN (1) CN103261156B (https=)
CA (1) CA2819171C (https=)
DK (1) DK2651888T3 (https=)
ES (1) ES2637288T3 (https=)
GB (1) GB201021103D0 (https=)
HR (1) HRP20171186T1 (https=)
HU (1) HUE033277T2 (https=)
SI (1) SI2651888T1 (https=)
WO (1) WO2012080221A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021104D0 (en) 2010-12-13 2011-01-26 Univ Leuven Kath Novel compounds for the treatment of neurodegenerative diseases
GB201021103D0 (en) 2010-12-13 2011-01-26 Univ Leuven Kath New compounds for the treatment of neurodegenerative diseases
CA2935683A1 (en) * 2013-12-30 2015-07-09 Lifesci Pharmaceuticals, Inc. Therapeutic inhibitory compounds
AP2016009347A0 (en) * 2014-01-29 2016-07-31 Neuropore Therapies Inc Heteroarly amides as inhibitors of protein aggregation
CN104744353B (zh) * 2015-03-31 2017-11-24 山东友帮生化科技有限公司 2‑氨基‑3‑碘‑5‑氯吡啶的合成方法
CN105130978B (zh) * 2015-07-22 2017-11-21 中国人民解放军军事医学科学院基础医学研究所 一种化合物及其在帕金森疾病方面的应用
EP3328379B1 (en) 2015-07-29 2021-07-28 UCB Biopharma SRL Bis-heteroaryl derivatives as modulators of protein aggregation
JP2019533022A (ja) 2016-10-24 2019-11-14 ユマニティ セラピューティクス,インコーポレーテッド 化合物及びその使用
EP3566055B1 (en) 2017-01-06 2025-03-12 Janssen Pharmaceutica NV Scd inhibitor for the treatment of neurological disorders
CN110198938B (zh) 2017-01-26 2023-03-14 Ucb生物制药私人有限公司 作为蛋白质聚集调节剂的双-杂芳基衍生物
EA201991755A1 (ru) 2017-01-26 2020-01-22 Юсб Байофарма Спрл Бициклические бисгетероарильные производные в качестве модуляторов агрегации белков
KR20190112031A (ko) 2017-01-26 2019-10-02 유씨비 바이오파마 에스피알엘 단백질 응집의 조절제로서의 알콕시 비스-헤테로아릴 유도체
WO2018158160A1 (en) 2017-02-28 2018-09-07 Universitat Autonoma De Barcelona (nitro-phenyl)-nitropyridine compounds for treating synucleinopathies
WO2019025424A1 (en) 2017-08-04 2019-02-07 Universitat Autonoma De Barcelona COMPOUNDS FOR TREATING SYNUCLEINOPATHIES
CA3083000A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. Compounds and uses thereof
WO2019161917A1 (en) 2018-02-23 2019-08-29 Universitat Autonoma De Barcelona 4-substituted 1-ethenylsulfonyl-2-nitrobenzene compounds for treating synucleinopathies
WO2019183587A1 (en) 2018-03-23 2019-09-26 Yumanity Therapeutics, Inc. Compounds and uses thereof
MX2021003904A (es) 2018-10-05 2021-10-26 Annapurna Bio Inc Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor apj.
WO2020154571A1 (en) 2019-01-24 2020-07-30 Yumanity Therapeutics, Inc. Compounds and uses thereof
WO2020198026A1 (en) * 2019-03-22 2020-10-01 Yumanity Therapeutics, Inc. Compounds and uses thereof
JP7731868B2 (ja) * 2019-08-02 2025-09-01 エースロット,インコーポレイテッド TDP-43、α-シヌクレイン、ハンチンチンタンパク質及びタウタンパク質のオリゴマー形成に関連する疾患を治療するための小分子薬物、並びに関連する方法
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345376A (en) * 1963-11-06 1967-10-03 Upjohn Co Polyhydro-6-methoxy-1-(3, 4, 5-trimethoxyphenyl)-9h-pyrido[3, 4-b]indoles
IL130169A (en) * 1999-05-27 2006-08-20 Neurim Pharma 1991 Indole derivatives, and pharmaceutical preparations, skin protection preparations, and cosmetics containing them
US6306890B1 (en) 1999-08-30 2001-10-23 Vanderbilt University Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
GB9922171D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
EP1284266A4 (en) 2000-05-02 2005-11-16 Meiji Seika Kaisha NEW INDOIND DERIVATIVES WITH CHYME-INHIBITABLE ACTIVITIES AND METHOD FOR THEIR PREPARATION
DOP2002000332A (es) * 2001-02-14 2002-08-30 Warner Lambert Co Inhibidores de piridina de metaloproteinasas de la matriz
DK1603570T5 (da) 2003-02-26 2013-12-09 Sugen Inc Aminoheteroarylforbindelser som proteinkinaseinhibitorer
EP1781609A4 (en) 2004-07-01 2009-07-29 Univ California INHIBITION OF A PDZ DOMAIN INTERACTION BY SMALL MOLECULES
WO2006058088A2 (en) 2004-11-23 2006-06-01 Ptc Therapeutics, Inc. Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
BRPI0613229A2 (pt) * 2005-07-12 2011-01-04 Bayer Cropscience Sa compostos, processo para a preparação de composto, composição fungicida e método para o combate curativo ou preventivo de fungo fitopatogênico
EP2149552A1 (de) * 2008-07-30 2010-02-03 Bayer Schering Pharma AG 5,6 substituierte Benzamid-Derivate als Modulatoren des EP2-Rezeptors
CA2751534A1 (en) * 2009-03-03 2010-09-10 Pfizer Inc. Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
GB0910003D0 (en) * 2009-06-11 2009-07-22 Univ Leuven Kath Novel compounds for the treatment of neurodegenerative diseases
ES2360435B1 (es) * 2009-10-30 2012-05-04 Consejo Superior De Investigaciones Cientificas (Csic) (70%) Derivados de biss (aralquil) amino y sistemas (6+5)-heteroaromaticos y su uso en el tratamiento de patologias neurodegenerativas, incluida la enfermedad de alzheimer
WO2012042621A1 (ja) * 2010-09-29 2012-04-05 味の素株式会社 塩味増強剤
AU2011329233A1 (en) 2010-11-15 2013-05-23 Abbvie Deutschland Gmbh & Co Kg NAMPT and ROCK inhibitors
GB201021103D0 (en) 2010-12-13 2011-01-26 Univ Leuven Kath New compounds for the treatment of neurodegenerative diseases
GB201021104D0 (en) 2010-12-13 2011-01-26 Univ Leuven Kath Novel compounds for the treatment of neurodegenerative diseases

Similar Documents

Publication Publication Date Title
JP2013544872A5 (https=)
HRP20171186T1 (hr) Derivati n-((1h-indol-3-il)-alkil)-4-benzil)benzamida i n-((1h-pirolo[2,3b]piridin-3-il)-alkil)-4-benzil)benzamida kao inhibitori nakupljanja alfa sinukleina za liječenje neurodegenerativnih poremećaja
AU2019283837B2 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
CA2395717C (en) Fused imidazolium derivatives
JPWO2010110231A1 (ja) 置換された3−ヒドロキシ−4−ピリドン誘導体
CA2961393A1 (en) Indoleamine-2,3-dioxygenase inhibitor and preparation method therefor
JP2000072773A (ja) プリン誘導体
JP2017533968A5 (https=)
JP2012513416A5 (https=)
EP1601649A2 (en) A1 adenosine receptor antagonists
JP2007500222A5 (https=)
JP2015535849A (ja) 新規化合物、それらの合成及びそれらの使用
HUP9903797A2 (hu) Benzofurán-karboxamidok és -szulfonamidok, alkalmazásuk gyógyszerkészítmények előállítására és ezek a gyógyszerkészítmények
JP2019529468A (ja) mGluR2陰性アロステリック調節剤としてのクロマン、イソクロマン及びジヒドロイソベンゾフラン誘導体、組成物、及びそれらの使用
RU2010113358A (ru) Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов
WO2016210345A1 (en) Composition and methods for inhibiting mammalian sterile 20-like kinase 1
WO2023018480A1 (en) Selective psychedelic compounds
JP2015502371A5 (https=)
WO2001042244A1 (en) Novel 1,8-naphthyridin-2(1h)-one derivatives
EP2970128A1 (en) Base addition salts of nitroxoline and uses thereof
US20150315130A1 (en) New positive allosteric modulators of nicotinic acetylcholine receptor
JPWO2006137465A1 (ja) 含窒素複素環誘導体
JP2021503451A5 (https=)
US7419997B2 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
US20120252853A1 (en) Positive allosteric modulators of nicotinic acetylcholine receptor